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In acidic and neutral solutions, cystinedihydroxamic acid (H2L2+)
binds ferric ion forming monomeric and dimeric complexes of 1:1,
2:2 and 2:3 metal to ligand stoichiometry. Comparison of the ob-
tained equilibrium and spectral data for mono(cystinedihydroxa-
mato)iron(III) with those of other hydroxamatoiron(III) complexes
suggests the same mode of coordination. The Fe2L3 complex has
been isolated and characterized by elemental analysis and IR spec-
tra.
INTRODUCTION
Metal ion complexes of hydroxamic acids have drawn much attention
due to their biological and clinical significance. They are biologically active
as antibiotics, growth factors, tumour inhibitors, pigments and iron seques-
tering agents.1–5 A natural linear trihydroxamic acid desferrioxamine B, is
used in human medicine to remove excess iron in patients suffering from
iron overload as a consequence of the treatment of Cooley's anemia, or acute
iron poisoning. Removal of excess aluminium from the human body by the
use of desferrioxamine B appears to be of importance in those patients who
must undergo permanent hemodialysis.6,7 Hydroxyurea, the simplest ami-
nohydroxamic acid, shows antitumour activity and has been introduced into
cancer therapy.8 In an attempt to design iron(III) chelates as suitable
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sources of iron in animal nutrition, iron(III) complexes with acet-, glycine-
and histidinehydroxamic acid have been studied with promising results.9,10
Naturally occurring hydroxamic acids, such as desferrioxamine B, have
typically three bidentate binding sites, making them hexadentate ligands.
However, a small group of these compounds have only two hydroxamate
binding sites. The most well-known example is rhodotorulic acid which
forms a highly stable Fe(III) complex between pH 3 and 12.11 A unique fea-
ture of dihydroxamic acids is their bifunctionality which gives them propen-
sity to form dinuclear species of Fe2L3 stoichiometry.
12 Iron(III) dihydroxa-
mate complexes have been proposed as contrast agents for NMR-imaging in
medical diagnosis.13 A series of dihydroxamic acids and their iron(III) com-
plexes have been studied, but no ligand with sulphur atoms in the chain
bridging two hydroxamate groups has been described to date. This paper
deals with the properties of iron(III)-cystinedihydroxamato complexes.
RESULTS AND DISCUSSION
Acid-Base Properties of Cystinedihydroxamic Acid
In a common aqueous titration range, protonated cystinedihydroxamic
acid could liberate four protons, two from protonated amino groups (NH3
+),




A potentiometric titration of the completely protonated ligand with po-
tassium hydroxide revealed that four protons were titrated per ligand mole-
cule. The obtained ionization constants are given in Table I. Comparison of
these data with those for a series of dihydroxamic acids suggests that pK a3
and pK a4 may be attributed to the two hydroxamate groups.
14 The observed
differences between the two pKa values for the two hydroxamic acid groups
as well as for the two amino groups are larger than 0.6 units. This is not
consistent with the equivalent non-interacting site model which predicts a
difference of 0.602 for two protonation sites that have the same intrinsic
acidity, e.g. equal microscopic pKa values, and are sufficiently removed from
each other as to be completely non-reacting. This difference arises from sta-
tistical effects, since the second deprotonation step can only occur from a
molecule that has already lost one proton. The obtained difference can be
explained by the intramolecular hydrogen bonding throughout the cystine-
dihydoxamic acid molecule which brings two hydroxamate groups into close
proximity, the behaviour of each of them becoming dependent on the other.




Formation of Mono(cystinedihydroxamato)iron(III) Complex
When an acidic aqueous solution of iron(III) is mixed with cystinedihy-
droxamic acid, a violet-red coloured complex is formed. The visible spectra
of this complex, as a function of pH and iron(III) concentrations, are shown
in insets of Figures 1 and 2, respectively.
The first step in the overall cystinedihydroxamato-iron(III) complexes
formation is expected to be the formation of the mono(cystinedihydroxa-
mato)iron(III) species. Coordination of the second ligand molecule could be
avoided by keeping Fe(III) in excess over the hydroxamic acid in solutions.
However, the two hydroxamate groups of H2L
2+ allow the possibility of for-
mation of a bimetallic species such as Fe2L
6+. Figure 2 shows the ratio of
the total iron(III) concentration and the absorbance plotted vs. the total
iron(III) concentration. The absorption data were collected at lmax = 482
nm, where hydrated iron(III) ion does not exhibit significant absorption.
The obtained linear relationship suggests that only one complex exists un-
der these experimental conditions.15 Hill's plot with a slope of about 0.9,
shown in Figure 1, suggests that one H+ ion is released per one H2L
2+ in the
complexation reaction in the pH = 0.4–1.9 range. This means that equation
(1) appropriately describes the equilibrium. The spectral data analysis con-
firmed the existence of only one complex under such experimental condi-
tions, with 1:1 stoichiometry and one proton released in the complexation.
The fact that lmax = 482 nm is not changed in Figures 1 and 2 also confirms
this findings. All these results suggest that the Fe2L
6+ complex has not been
formed. This is in agreement with the expected electrostatic repulsion be-
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TABLE I
Equilibrium and spectral data for the cistinedihydroxamate acid and its iron(III)
complexes, t = 25 °C, I = 0.1 M (KNO3)
Specification Cistinedihydroxamic acid
Acidic constants pKa1 (-NH3+) 5.36 (0.05)
pKa2 (-NH3+) 6.52 (0.03)
pKa3 (-NHOH) 8.60 (0.02)
pKa4 (-NHOH) 9.63 (0.02)
Complex formation
constants
log  (FeHL4+) 18.93 (0.02) 19.0*
log  (Fe2L26+) 33.91 (0.13)
log  (Fe2L3 6+) 46.44 (0.10)
Molar absorptivities e  103 M–1cm–1 (FeHL4+) 1.96 1.70*
e  103 M–1cm–1 (Fe2L26+) 2.62
e  103 M–1cm–1 (Fe2L36+) 3.41
* at ionic strength of 1.0 M (KNO3)
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Figure 2. The ratio of the total iron(III) concentration to the absorbance at 482 nm
vs. total iron(III) concentration. Inset: Solution spectra of the iron(III) complex with
cystinedihydroxamic acid at various Fe3+tot. H+ = 0.022, CYStot = 5  10–4, I =
1.0 M (KNO3), T = 25 °C, Fe3+tot = 5  10–4 – 1  10–2.
Figure 1. Determination of the number of hydrogen ions involved in the equilibrium
(1). Molar absorptivity used for the calculation Amax at 482 nm is obtained from the
plot depicted in the inset of Figure 1. Inset: Solution spectra of the iron(III) complex
with cystinedihydroxamic acid at various pH. Fe3+tot = 5  10–3, CYStot = 1  10–3,
I = 1.0 M (KNO3) T = 25 °C, H+ = 0.012–0.417.
tween the positively charged two iron centres bridged by the coordinated
cystinedihydroxamic acid, as proposed for analogous dinuclear complexes of
iron(III) and some aliphatic dihydroxamic acids.16
H2L
2+ + Fe3+  FeHL H4+ + (1)
A general rule has been accepted17 according to which the molar absorp-
tivity of an iron(III) hydroxamate complex is about 1000n M–1 cm–1, n being
the number of hydroxamate groups bonded per iron(III) ion. The obtained
molar absorptivity of 1700 M–1 cm–1 is higher than usual for monohydroxa-
mato iron(III). This may be explained by the existence of positive charges on
the complex (NH3
+), which increases the degree of solvation and thereby
molar absorptivity. The difference between equilibrium constants for the
mono(cystinedihydroxomato) iron(III) (log K = 0.70) and the analogous iron
complex of the ligand with six atoms in the aliphatic chain between the two
hydroxamate groups (log K = 1.79) may be reasonably rationalized taking
into account the positive charges on the ligand.16 Our preliminary kinetic
results indicate that the rate constant for the reaction between H2L
2+ and
FeOH2+ (k = 8.75  103 M–1 s–1) is of the same magnitude as that obtained
for numerous other hydroxamic acids, i.e. monohydroxamic acids,18–20 dihy-
droxamic acids,16 and desferrioxamine B.21,22 Therefore, the observed labil-
ity of FeHL4+ is a result of the ease with which the ligand dissociates from
the complex due to the high positive charge.
Formation of Bimetallic Iron(III) Cystinedihydoxamic Acid Complexes
In the solutions of cystinedihydroxamic acid in excess over iron(III), de-
pending on the hydrogen ion concentration, formation of higher complex
species takes place. However, very low solubility of the complexes formed at
pH > 3 and at high ionic strength makes the concentration range for the
stability constants study too narrow. In order to extend this range, we ran
experiments at an as low as possible ionic strength. Figure 3 shows the
spectral data acquired at constant ionic strength maintained by 0.1 M
KNO3, which allowed experiments to be performed at pH up to 5. Treatment
of these spectra showed that a satisfactory fit was obtained only for the
complexes of FeHL4+, Fe2L2
6+ and Fe2L3
6+ stoichiometry. As shown in Figure
4, the calculated absorbancies are in good agreement with experimental
data points. Distribution of the proposed complex species in the pH range
0.5–5 is shown in Figure 5. As shown in Table I, formation constants for the
Fe2L3
6+ (log b = 46.4) complex are much lower than for rhodotorulic acid (log
b = 62.2).11 The obtained difference may be reasonably rationalized in terms
of a high positive charge of Fe2L3
6+ due to the protonation of amino groups
in the pH range studied.
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Figure 4. Dependence of the absorbance at 486 nm on pH of solution. Conditions as
in Figure 3. The solid line represents fit of the data to the stability constants and
molar absorptivities given in Table I.
Figure 3. Solution spectra of the iron(III) complex with cystinedihydroxamic acid at
various H+. Fe3+tot = 5  10–3 , CYStot = 1  10–3, I = 0.1 M (KNO3) T = 25 °C, pH
= 0.012–0.417.
When the reaction solution pH was increased over 5, a dark purple com-
plex precipitated. Analysis of this product showed Fe2L3 composition. An IR
spectrum of this complex reveals absence of OH stretching frequency at
3038 cm–1 and a broad carbonyl stretching band at 1635 cm–1, confirming a
normal (O,O) coordination of the iron atoms with cystinedihydroxamic acid,
like in the natural iron(III) complex with rhodotorulic acid. The carbonyl
frequency in the complex is shifted by 26 cm–1 to a higher energy than that
in the free ligand in solid state. The most likely explanation of this unex-
pected observation lies in the formation of strong intramolecular hydrogen
bonding involving the carbonyl oxygen of one hydroxamic group with hydro-
gen atom of hydroxyl group of the other hydroxamic moiety.23
The X-ray structural reports on iron(III) complexes with hydroxamic ac-
ids show that complexation occurs by coordinating both the C=O and OH
oxygen atoms of the hydroxamic group to the iron(III) centre forming the
five-member chelate ring.24 This happens with concomitant loss of the NOH
proton. The presence of another functional group in a hydroxamic acid mole-
cule, such as -NH2 or S, offers the possibility of forming a complex in which
such a group participates as electron pair donor.25 However, the results pre-
sented above along with our earlier results with betainehydroxamic acid
and glycinehydroxamic acid,26 indicate that the coordination of iron through
the -NH2 or -S groups is not likely with cystinedihydroxamic acid.
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Figure 5. Distribution of different iron(III) species as a function of pH. Conditions as
in Figure 3.
EXPERIMENTAL
Cystinedihydroxamic acid was purchased from Sigma Chem. Co. (St.Louis) and
its purity was checked potentiometrically. All other reagents were of analytical
grade and were used without further purification. Double distilled water in an all-
glass apparatus was used throughout the experiments.
Equilibrium absorbance data were collected using a Hewlett-Packard 8452A
diode-array spectrophotometer. In spectrophotometric titrations, the solution was
circulated to the spectrophotometer cell through polyethylene tubing with a peristal-
tic pump. Once equilibrium was established, the pump and stirrer were turned off
just long enough to measure the pH and acquire spectra.
The IR spectra were obtained by using a FT-IR Perkin-Elmer Paragon 500 spec-
trometer from samples dispersed in KBr pellets.
The pH measurements were carried out in a water-jacketed cell maintained at
25  0.1 °C by an external circulation bath. The Radiometer model PHM 85 digital
pH-Meter with combination glass electrode (Radiometer GK 2322C) was used for pH
readings.
The pKa values of cystinedihydroxamic acid were determined by titrations with
carbonate-free sodium hydroxide at ionic strength of 0.1 M (KNO3) under a purified
nitrogen atmosphere. All other experiments were performed in aqueous solutions of
0.1 or 1.0 M ionic strength (KNO3) defined as 0.5 Ci × Zi2, where Ci and Zi are total
concentrations, and the formal charge numbers of the ions present in the solution,
respectively.
The spectrophotometric data reduction analysis was performed using SPECFIT-
program. A SUPERQUAD computer program was used for the refinement of pKa val-
ues from the titration data.27
Preparation of Fe2L3
Cystinedihydroxamic acid (1.6391 g, 5.46 mmol) was dissolved in 300 mL water
by addition of HNO3 to pH 1.5. To this solution, Fe(NO3)3 × 9H2O (735 mg, 1.82 mmol)
dissolved in 50 mL of water was slowly added under constant stirring. Then, the pH
of this solution was raised (pH 4) by dropwise addition of 1.0 M KOH. To this solution,
saturated KNO3 was added until precipitation occurred. The obtained product was
allowed to stand overnight. The dark purple precipitate was filtered off, washed with
water and dried in air and finely in vacuo over P4O10 at room temperature for 72 h.
Anal. Calcd. for C18H36N12O12S6Fe2 	 7H2O Mr=(1042.7): Fe 10.71, S 18.45, C
20.73%; found: Fe 10.73, S 18.42, C 19.17%. IR(KBr): n/cm–1 3433 (NH)st, 1635
(CO)st.
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SA@ETAK
Kompleksacija `eljeza(III) sa cistindihidroksamnom kiselinom
Mladen Biru{, Suzana Ini}, Nikola Kujund`i} i Biljana Nigovi}
U kiselim i neutalnim otopinama cistindihidroksamna kiselina (H2L2+) ve`e
`eljezov(III) ion stvaraju}i monomerne i dimerne komplekse u omjerima Fe : L = 1 : 1,
2 : 2 i 2 : 3. Usporedba ravnote`nih i spektralnih parametara mono(cistindihidroksa-
mato) `eljezova(III) kompleksa s drugim `eljezovim(III) hidroksamatima upu}uje na
jednak na~in koordinacije. Izoliran je kompleks Fe2L3 i karakteriziran na osnovi ele-
mentne analize i IR-spektra.
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